Xiaojing Guo

No. 800 Xiangyin Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Redox biology in PCOS: Biomarkers, mechanistic networks, and targeted interventions (Review).

Redox biology in PCOS: Biomarkers, mechanistic networks, and targeted interventions (Review).

Journal: International journal of molecular medicine

Published: November 23, 2025

SIRT1 inhibits ferroptosis of granulosa cells in polycystic ovarian syndrome.

SIRT1 inhibits ferroptosis of granulosa cells in polycystic ovarian syndrome.

Journal: International journal of biological macromolecules

Published: June 08, 2025

Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome.

Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome.

Journal: Drug design, development and therapy

Published: March 01, 2025

Regulation of the EGFR/PI3K/AKT signaling cascade using the Shengui Yangrong Decoction improves ovulation dysfunction and insulin resistance in polycystic ovary syndrome.

Regulation of the EGFR/PI3K/AKT signaling cascade using the Shengui Yangrong Decoction improves ovulation dysfunction and insulin resistance in polycystic ovary syndrome.

Journal: Fitoterapia

Published: September 10, 2024

From Pathophysiology to Treatment: The Role of Ferroptosis in PCOS.

From Pathophysiology to Treatment: The Role of Ferroptosis in PCOS.

Journal: Frontiers in bioscience (Landmark edition)

Published: July 08, 2024

Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.

Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.

Journal: Expert opinion on drug safety

Published: February 23, 2022

Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS.

Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS.

Journal: Frontiers in pharmacology

Published: August 28, 2021

Hematological toxicities in immune checkpoint inhibitors: A pharmacovigilance study from 2014 to 2019.

Hematological toxicities in immune checkpoint inhibitors: A pharmacovigilance study from 2014 to 2019.

Journal: Hematological oncology

Published: October 28, 2019

Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?

Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: September 15, 2019

Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.

Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.

Journal: Journal for immunotherapy of cancer

Published: July 14, 2019

Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.

Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.

Journal: BMJ open

Published: November 25, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026